Public attitudes diverge sharply on legal use of psychedelics

Mental Health Weekly 2026

View at publisher
Authors: Valerie A. Canady
DOI: 10.1002/mhw.34775
Cited by: 0

Abstract

Support for the legal use of psilocybin mushrooms (23%) is much lower than it is for cannabis (65%), according to a new RAND research report, released Feb. 24. For LSD and 3,4‐methylenedioxymethamphetamine (MDMA)–assisted therapy, support for legal use is closer to 10%.

Fields of Study & Subjects

Psychedelics and Drug Studies Cannabis and Cannabinoid Research Mental Health Treatment and Access

Publication details

Journal / source
Mental Health Weekly
Volume
36
Issue
9
Pages
5–6
Publication date
2 March 2026
Language
EN